Mark Pruzanski

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical compositions for combination therapy
- Patent number 11,311,557
- Issue date Apr 26, 2022
- Intercept Pharmaceuticals, Inc.
- Mark Pruzanski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of fibrosis using FXR ligands
- Patent number 10,987,362
- Issue date Apr 27, 2021
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FXR agonist compositions for combination therapy
- Patent number 10,894,054
- Issue date Jan 19, 2021
- Intercept Pharmaceuticals, Inc.
- Mark Pruzanski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of obeticholic acid and methods of use
- Patent number 10,758,549
- Issue date Sep 1, 2020
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions of obeticholic acid and methods of use
- Patent number 10,751,349
- Issue date Aug 25, 2020
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of obeticholic acid and methods of use
- Patent number 10,646,499
- Issue date May 12, 2020
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of fibrosis using FXR ligands
- Patent number 10,258,633
- Issue date Apr 16, 2019
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of obeticholic acid and methods of use
- Patent number 10,052,337
- Issue date Aug 21, 2018
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 9,763,964
- Issue date Sep 19, 2017
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of fibrosis using FXR ligands
- Patent number 9,498,484
- Issue date Nov 22, 2016
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 9,090,652
- Issue date Jul 28, 2015
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 8,546,365
- Issue date Oct 1, 2013
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 7,932,244
- Issue date Apr 26, 2011
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 7,858,608
- Issue date Dec 28, 2010
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
- Publication number 20220280534
- Publication date Sep 8, 2022
- Intercept Pharmaceuticals, Inc.
- Mark Pruzanski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
- Publication number 20220280533
- Publication date Sep 8, 2022
- Intercept Pharmaceuticals, Inc.
- Mark Pruzanski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
- Publication number 20220133745
- Publication date May 5, 2022
- Intercept Pharmaceuticals, Inc.
- Richard Gail LANCASTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF FIBROSIS USING FXR LIGANDS
- Publication number 20210346400
- Publication date Nov 11, 2021
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF FIBROSIS USING FXR LIGANDS
- Publication number 20200397803
- Publication date Dec 24, 2020
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF FIBROSIS USING FXR LIGANDS
- Publication number 20200197414
- Publication date Jun 25, 2020
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
- Publication number 20200171053
- Publication date Jun 4, 2020
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
- Publication number 20200054650
- Publication date Feb 20, 2020
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
- Publication number 20200046735
- Publication date Feb 13, 2020
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
- Publication number 20200046736
- Publication date Feb 13, 2020
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
- Publication number 20190255071
- Publication date Aug 22, 2019
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
- Publication number 20190076446
- Publication date Mar 14, 2019
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
- Publication number 20180117065
- Publication date May 3, 2018
- Intercept Pharmaceuticals, Inc.
- Mark Pruzanski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Pulmonary Disease
- Publication number 20180064729
- Publication date Mar 8, 2018
- Intercept Pharmaceuticals, Inc.
- Mark Pruzanski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
- Publication number 20180008616
- Publication date Jan 11, 2018
- Intercept Pharmaceuticals, Inc.
- Mark Pruzanski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF FIBROSIS USING FXR LIGANDS
- Publication number 20170165277
- Publication date Jun 15, 2017
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
- Publication number 20170035784
- Publication date Feb 9, 2017
- Intercept Pharmaceuticals, Inc.
- Richard Gail Lancaster
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Pulmonary Disease
- Publication number 20160213689
- Publication date Jul 28, 2016
- Intercept Pharmaceuticals, Inc.
- Mark Pruzanski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatmen...
- Publication number 20150359805
- Publication date Dec 17, 2015
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Pulmonary Disease
- Publication number 20140148428
- Publication date May 29, 2014
- Mark Pruzanski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatmen...
- Publication number 20140057886
- Publication date Feb 27, 2014
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatmen...
- Publication number 20120283234
- Publication date Nov 8, 2012
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BILE ACID DERIVATIVES AS FXR LIGANDS FOR THE PREVENTION OR TREATMEN...
- Publication number 20100063018
- Publication date Mar 11, 2010
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Publication number 20080182832
- Publication date Jul 31, 2008
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of reducing drug-induced adverse side effects in a patient
- Publication number 20060252670
- Publication date Nov 9, 2006
- Intercept Pharmaceuticals Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of fibrosis using FXR ligands
- Publication number 20060069070
- Publication date Mar 30, 2006
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark Pruzanski

Person

Patents Grantslast 30 patents

Pharmaceutical compositions for combination therapy

Treatment of fibrosis using FXR ligands

FXR agonist compositions for combination therapy

Compositions of obeticholic acid and methods of use

Compositions of obeticholic acid and methods of use

Compositions of obeticholic acid and methods of use

Treatment of fibrosis using FXR ligands

Compositions of obeticholic acid and methods of use

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Treatment of fibrosis using FXR ligands

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Patents Applicationslast 30 patents

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

TREATMENT OF FIBROSIS USING FXR LIGANDS

TREATMENT OF FIBROSIS USING FXR LIGANDS

TREATMENT OF FIBROSIS USING FXR LIGANDS

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

Treatment of Pulmonary Disease

PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

TREATMENT OF FIBROSIS USING FXR LIGANDS

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

Treatment of Pulmonary Disease

Bile Acid Derivatives as FXR Ligands for the Prevention or Treatmen...

Treatment of Pulmonary Disease

Bile Acid Derivatives as FXR Ligands for the Prevention or Treatmen...

Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatmen...

BILE ACID DERIVATIVES AS FXR LIGANDS FOR THE PREVENTION OR TREATMEN...

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Method of reducing drug-induced adverse side effects in a patient

Treatment of fibrosis using FXR ligands